Global Antiviral Therapies Market Projected to Beat $66,016.5 Million, Growing at 3.1% CAGR from 2020 to 2027 [208-Pages] | Exclusively Available at Research Dive

New York, USA, March 07, 2022 (GLOBE NEWSWIRE) — A new report on the global antiviral therapies market has been added by Research Dive to its repository. According to the report, the global market is expected to hit $66,016.5 million by 2027, rising at a CAGR of 3.1% from 2020 to 2027. This report in an in-depth study offering meticulous insights into the present situation and future scope of the global industry. The report is drafted by expert market analysts and assures to be a reliable source of data and comprehensive market insights for new market players, investors, prevalent players, stakeholders, shareholders, etc.

Impact of COVID-19 Pandemic on the Antiviral Therapies Market:

The abrupt rise of COVID-19 pandemic in 2020 has had an optimistic impact on the growth of the global antiviral therapies market. In the pandemic period, researchers are greatly investing in R&D activities to find effective antiviral drugs for the COVID-19 treatment. Moreover, many market players are striving to recognize suitable compounds with high antiviral activity against coronavirus infection to deliver instant solution and end the pandemic. This has boosted the global market growth significantly during the pandemic crisis.

Know-How COVID-19 Pandemic Impacted on Antiviral Therapies Market. Click Here to Schedule your call with an Expert Analyst & Avail Full Report -$2999 (Read-Only)

Factors Impacting the Antiviral Therapies Market Growth:

Growing cases of viral infections worldwide and the growing demand for antiviral drugs for curing HIV are the main factors fueling the growth of the global antiviral therapies market. Additionally, the integration of nanotechnology into antiviral drugs design & development for the production of advanced and cost-effective medications is projected to bring in lucrative growth opportunities for the market in the forecast period. However, lengthy procedures involved in the development and launch of antiviral drugs is projected to hamper the growth of the antiviral therapies industry.

The report segments the global antiviral therapies market into drug type, distribution channel, and region.

HIV Antiviral Drug Sub-Segment to Experience Remarkable Growth

Among the drug type segment, the HIV antiviral drug sub-segment grabbed highest market share in 2019, and is expected to experience significant growth during the forecast period. The growth of this sub-segment is mostly because of the rising demand for HIV antiviral drugs due to significant surge in the cases of HIV across the world.

Get | Download an Exclusive PDF Sample of Antiviral Therapies Market

Hospital Pharmacy Sub-Segment to Observe Highest Growth

Among the distribution channel segment, the hospital pharmacy sub-segment is projected to grab leading market share and grow with 2.8% CAGR during the estimated timeframe. This is mostly because hospital pharmacies offer quality drugs to patients by procuring the drugs directly from medicine manufacturers, consequently avoiding the problem of forged drugs.

North America Region to Observe Steady Growth

The report analyzes the global antiviral therapies market across several regions such as North America, Europe, Asia Pacific, and LAMEA. Among these, the North America region market is expected to grow continuously during the estimated timeframe. The growth of this region market is mainly owing to the rising demand for antiviral medicines owing to the presence of viral infections and increasing geriatric population in the region.

Request On-Demand Customized Report of Antiviral Therapies Market & Avail 10%OFF

Major Players in the Antiviral Therapies Market:

The report lists some of the major key players functioning in the global antiviral therapies market including

1. Gilead Sciences, Inc.
2. AstraZeneca
3. F. Hoffmann-La Roche Ltd
4. Merck & Co., Inc.
5. Bristol-Myers Squibb Company
6. Johnson & Johnson Services, Inc.
7. Abbott
8. AbbVie Inc.
9. Aurobindo Pharma
10. GlaxoSmithKline plc., and others.

The report also offers several industry-top tactics and approaches such as top strategic moves & developments, product/service range, business performance, Porter five forces analysis, and SWOT analysis of the foremost players, functioning in the global industry. – Inquire to Get access to Detailed Top Companies Development Strategy Report

For instance, in April 2021, the government of the UK introduced an Antivirals Taskforce to detect treatments that can be used at home by people infected with SARS-CoV-2 infection, to avoid the spread of the virus and accelerate recovery time.

Related Article Links: